PharmaTelevision - DSM Pharmaceuticals: Xander Wessels explains how DSM has adapted to changes in pharma industry

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: DSM Pharmaceuticals: Xander Wessels explains how DSM has adapted to changes in pharma industry

Visitors: You are watching a 30 seconds preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Xander Wessels, CEO of DSM Pharmaceuticals.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

How does DSM adapt to changes in the pharma industry?

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at BIO 2011 in Washington DC. On this show I have Alexander Wessels, who is CEO of DSM Pharmaceutical Products, welcome to the show.

JAlexander Wessels:

Thank you. Nice to meet you.

Fintan Walton:

Nice to meet you too. Alexander, DSM is a company that is a contract manufacturer known mainly as a contract manufacturing company its position within the pharmaceutical industry that pharmaceutical industry has undergone a lot of change recently, could you tell us a little bit how DSM operates within the pharmaceutical industry and how you've changed as the industry is changed.

JAlexander Wessels:

Yes, well first of all the DSM is more than just contract manufacturing, so we have an active pharmaceutical ingredient division, we have the anti-infectives division, we are building a biomedical material division and then we have contract manufacturing and in that contract manufacturing ends we of course see more outsourcing taking place and if you then look to like bigger trends we likely see that the customers go for like deeper partnerships where it's not all about outsourcing products but almost about outsourcing portfolios really where you become like the total manufacturing arm of over customer and there is really long-term ties that tie the supplier and the customer together into like one flawless supply chain.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Alexander R Wessels

President

Alexander R. Wessels MSc, MBA is President and Chief Executive Officer of DSM Pharmaceutical Products business group. He has worked in the nutrition and life sciences industries for 20 years, including 4 years at DSM , most recently as Business Group President of DSM Food Specialties.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

DSM Pharmaceutical Products

DSM Pharmaceutical Products is the custom manufacturing and technology resource within Royal DSM NV a global life sciences and materials sciences company that delivers innovative products and services to create solutions that nourish, protect and improve performance. DSM offers services across the pharma value chain, combining the corporate strength of DSM with the focus and flexibility needed in partnerships with pharmaceutical and biopharmaceutical customers.